Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
- PMID: 9537327
- DOI: 10.1038/32932
Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction
Abstract
Viral infection and vaccination with DNA both induce similar immune responses to encoded antigens that are produced by the host. The availability of antigens in lymphoid organs is important in generating an immune response to viral challenge. Antigen availability may also be important in the response to DNA vaccines, because immune responses are stronger when antigen is secreted from DNA-transfected cells. We directed antigen to lymphoid organs by vaccination with DNA encoding antigen-ligand fusion proteins. The two ligands examined bind to receptors that are present on high endothelial venule cells of lymph nodes or on antigen-presenting cells. Here we show that both the humoral and the cellular immune responses to a model DNA vaccine were enhanced using either antigen-targeting strategy. Moreover, directing antigen to antigen-presenting cells speeded up, and altered the form of, the immune response. Directing antigen to sites of immune-response induction may represent a generic means of tailoring a potent and effective immune response to a DNA vaccine.
Similar articles
-
The comparative efficacy of CTLA-4 and L-selectin targeted DNA vaccines in mice and sheep.Vaccine. 2001 Aug 14;19(31):4417-28. doi: 10.1016/s0264-410x(01)00196-7. Vaccine. 2001. PMID: 11483267
-
A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6676-80. doi: 10.1073/pnas.120162497. Proc Natl Acad Sci U S A. 2000. PMID: 10823919 Free PMC article.
-
Site-directed immune responses in DNA vaccines encoding ligand-antigen fusions.Vaccine. 2000 Feb 25;18(16):1681-5. doi: 10.1016/s0264-410x(99)00506-x. Vaccine. 2000. PMID: 10689148
-
DNA vaccination: antigen presentation and the induction of immunity.J Leukoc Biol. 2000 Dec;68(6):793-806. J Leukoc Biol. 2000. PMID: 11129646 Review.
-
Bacterial systems for the delivery of eukaryotic antigen expression vectors.Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):391-9. doi: 10.1089/oli.1.2000.10.391. Antisense Nucleic Acid Drug Dev. 2000. PMID: 11079578 Review.
Cited by
-
Design of a novel multiepitope vaccine against Chlamydia pneumoniae using the extracellular protein as a target.Sci Rep. 2023 Sep 12;13(1):15070. doi: 10.1038/s41598-023-42222-x. Sci Rep. 2023. PMID: 37700027 Free PMC article.
-
Advances in the polymeric delivery of nucleic acid vaccines.Theranostics. 2022 May 13;12(9):4081-4109. doi: 10.7150/thno.70853. eCollection 2022. Theranostics. 2022. PMID: 35673570 Free PMC article. Review.
-
DNA Vaccines in Pigs: From Immunization to Antigen Identification.Methods Mol Biol. 2022;2465:109-124. doi: 10.1007/978-1-0716-2168-4_6. Methods Mol Biol. 2022. PMID: 35118618
-
Conserved HA-peptide NG34 formulated in pCMV-CTLA4-Ig reduces viral shedding in pigs after a heterosubtypic influenza virus SwH3N2 challenge.PLoS One. 2019 Mar 1;14(3):e0212431. doi: 10.1371/journal.pone.0212431. eCollection 2019. PLoS One. 2019. PMID: 30822308 Free PMC article.
-
Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.J Mater Chem B. 2014;46:8053-8068. doi: 10.1039/C4TB01058B. Epub 2014 Sep 12. J Mater Chem B. 2014. PMID: 29887986 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
